# Myrobalan Therapeutics Holding, Inc. — Form D

Myrobalan Therapeutics Holding, Inc. of MEDFORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-24. The offering totals $24.0M, of which $24.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-01-24
- Form: D
- Accession: 0002009058-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $24.0M
- Amount sold: $24.0M
- Investors: 12
- Date of first sale: 2024-01-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-503241

## Issuer

- Name: Myrobalan Therapeutics Holding, Inc.
- CIK: 0002009058
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 200 BOSTON AVENUE, SUITE G750, MEDFORD, MA, 02155
- Phone: 857-675-1485

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Guoping Feng | Director | MEDFORD, MA |
| Zhigang He | Director | MEDFORD, MA |
| Jing Yu Wang | Director | MEDFORD, MA |
| Shixiang Yan | Director | MEDFORD, MA |
| Minmin Yang | Director | MEDFORD, MA |
| Jing Yu Wang | Executive Officer | MEDFORD, MA |

## More

- [CIK 2009058 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2009058&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002009058-24-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.